News & Updates
Showing Multidisciplinary articles
Showing

French study highlights atezolizumab–bevacizumab benefit in HCC
Four-year updates from the CHIEF study show a durable survival benefit with atezolizumab plus bevacizumab in individuals with advanced hepatocellular carcinoma (HCC).
French study highlights atezolizumab–bevacizumab benefit in HCC
08 Sep 2026
Nose-only swabs a viable alternative to nose + throat swabs for flu and SARS-CoV-2 detection
According to an outpatient surveillance study in Hong Kong, minimally invasive nose-only swabs achieved high agreement with joint nose and throat swabs (NTS) for reverse transcription polymerase chain reaction (RT-qPCR) detection of influenza and SARS-CoV-2, thus presenting a viable alternative specimen type for supervised respiratory virus testing.
Nose-only swabs a viable alternative to nose + throat swabs for flu and SARS-CoV-2 detection
08 Sep 2026
Real-world study supports new therapeutics for BRAF-mutant metastatic CRC
A real-world study presented at ESMO GI 2026 shows that pembrolizumab immunotherapy and a combination regimen of encorafenib and cetuximab are associated with meaningful survival benefits in BRAF-mutant metastatic colorectal cancer (CRC).






